论文部分内容阅读
曾报道原发性卵巢癌患者血清乳酸脱氢酶有所增高,但在卵巢良性肿瘤,子宫平滑肌瘤,子宫内膜癌,子宫颈癌及乙状结肠癌则不增高。本文报道这一展望性研究的结果以进一步证实原发性卵巢癌血清乳酸脱氢酶的增高。材料与方法:研究了18例盆腔肿块的病人。每一病人均经有能力的妇科医生作过盆腔检查。初步诊断为盆腔肿块,并高度怀疑有卵巢瘤。每例均作术前术后血清乳酸脱氢酶测定。有1例仅作术前而未作术后测定。首次手术治疗为腹部子宫全截及双侧输卵管卵巢切除。1例仅作开腹探查及活检。某些病例附加放疗或化疗或二者并用。测定血清乳酸
It has been reported in patients with primary ovarian cancer serum lactate dehydrogenase increased, but in benign ovarian tumors, uterine leiomyoma, endometrial cancer, cervical cancer and sigmoid colon cancer is not increased. This paper reports the results of this prospective study to further confirm the elevation of serum lactate dehydrogenase in primary ovarian cancer. Materials and Methods: 18 patients with pelvic masses were studied. Each patient has been pelvic examination by a competent gynecologist. Initial diagnosis of pelvic mass, and a high degree of suspicion of ovarian tumor. Preoperative and postoperative serum lactate dehydrogenase was measured in each case. One case was only for preoperative and did not make postoperative determination. The first surgical treatment of abdominal full uterine segment and bilateral tubal ovariectomy. 1 case only for laparotomy and biopsy. Some cases of additional radiotherapy or chemotherapy or both. Determination of serum lactate